Subsequently, we observed that IGF2BP3 antibody‐precipitated SUCLG2‐AS1 was significantly reduced in NPC cells following METTL3 silencing (Figure 3P,Q). The gene discussed is SUCLG2; the disease is nasopharyngeal carcinoma.